GR3004071T3 - - Google Patents

Info

Publication number
GR3004071T3
GR3004071T3 GR920400469T GR920400469T GR3004071T3 GR 3004071 T3 GR3004071 T3 GR 3004071T3 GR 920400469 T GR920400469 T GR 920400469T GR 920400469 T GR920400469 T GR 920400469T GR 3004071 T3 GR3004071 T3 GR 3004071T3
Authority
GR
Greece
Prior art keywords
mammal
epo
hematocrit
pharmaceutically acceptable
effective amount
Prior art date
Application number
GR920400469T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21889805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3004071(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GR3004071T3 publication Critical patent/GR3004071T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Electrotherapy Devices (AREA)
GR920400469T 1987-04-10 1992-03-18 GR3004071T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3664687A 1987-04-10 1987-04-10

Publications (1)

Publication Number Publication Date
GR3004071T3 true GR3004071T3 (el) 1993-03-31

Family

ID=21889805

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400469T GR3004071T3 (el) 1987-04-10 1992-03-18

Country Status (13)

Country Link
US (1) US5541158A (el)
EP (1) EP0286439B1 (el)
JP (1) JP2858752B2 (el)
KR (1) KR880012235A (el)
AT (1) ATE70978T1 (el)
AU (1) AU613905B2 (el)
DE (1) DE3867285D1 (el)
DK (1) DK167903B1 (el)
ES (1) ES2035279T3 (el)
GR (1) GR3004071T3 (el)
IE (1) IE61008B1 (el)
NO (1) NO881507D0 (el)
PT (1) PT87197B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
CA2239808A1 (en) * 1995-12-21 1997-06-26 Antonio Tiongson Direct compression carbonyl iron tablet
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
PT977582E (pt) * 1997-03-18 2002-12-31 Roche Diagnostics Gmbh Preparacoes farmaceuticas associadas contendo eritropoietina e preparacoes de ferro
US7033774B2 (en) * 1997-04-21 2006-04-25 Glycozyme, Inc. Determination of recombinant glycosylated proteins and peptides in biological fluids
EP0885613A1 (de) * 1997-06-21 1998-12-23 Roche Diagnostics GmbH Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin
EP1053004A2 (en) 1998-02-09 2000-11-22 University Of Southern California Use of angiotensin analogues for promoting erythropoiesis
US7304150B1 (en) 1998-10-23 2007-12-04 Amgen Inc. Methods and compositions for the prevention and treatment of anemia
US6747002B2 (en) * 1999-05-11 2004-06-08 Ortho-Mcneil Pharmaceutical, Inc. Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
US7459435B2 (en) 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US7459436B2 (en) 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
EP1973549B1 (en) 2006-01-06 2016-07-20 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57149228A (en) * 1981-03-11 1982-09-14 Ajinomoto Co Inc Novel erythropoietin and its preparation
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
US4745099A (en) * 1985-02-06 1988-05-17 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of malignant tumors
JPS6231A (ja) * 1985-02-06 1987-01-06 Chugai Pharmaceut Co Ltd 腎性貧血治療剤
GB2177914B (en) * 1985-06-04 1989-10-25 Chugai Pharmaceutical Co Ltd A pharmaceutical composition containing human erythropoietin and a surface active agent for nasal administration for the treatment of anemia
US5013718A (en) * 1986-11-21 1991-05-07 Amgen, Inc. Method for treating iron overload using EPO
JPS63227527A (ja) * 1987-03-05 1988-09-21 キリン―アムジエン（デラウエア）インコーポレーテツド 貧血予防薬

Also Published As

Publication number Publication date
JP2858752B2 (ja) 1999-02-17
AU613905B2 (en) 1991-08-15
JPS63277630A (ja) 1988-11-15
ES2035279T3 (es) 1995-04-01
DK194288D0 (da) 1988-04-08
DK194288A (da) 1988-10-11
KR880012235A (ko) 1988-11-26
NO881507D0 (no) 1988-04-07
DE3867285D1 (de) 1992-02-13
AU1444588A (en) 1988-10-13
PT87197A (pt) 1988-05-01
ATE70978T1 (de) 1992-01-15
EP0286439B1 (en) 1992-01-02
US5541158A (en) 1996-07-30
DK167903B1 (da) 1994-01-03
IE61008B1 (en) 1994-09-07
IE881064L (en) 1988-10-09
EP0286439A1 (en) 1988-10-12
PT87197B (pt) 1992-07-31

Similar Documents

Publication Publication Date Title
GR3004071T3 (el)
OA09737A (en) "Stable interferon complexes"
EP0497977A4 (en) Gastric preparation
IL84275A (en) Pharmaceutical composition comprising erythropoietin for treatment of iron overload disorders
GB8806737D0 (en) Therapeutic composition & method
ZA889166B (en) 1,7-annelated indolecarboxylic acid esters and -amides
AR245221A1 (es) Un metodo para la produccion de acido clavulanico por fermentacion de s. clavuligerus
IL86862A (en) Pharmaceutical compositions for reducing the level of circulating immune complexes in vivo, containing mismatched double-stranded rna
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
HUT45256A (en) Process for producing 1,3,4,9-tetrahydropyrano/3,4-b/indol-1-acetic acid derivatives and pharmaceutical composition containing them
IL88513A0 (en) D1-5-((2-benzyl-3',4-dihydro-2h-benzopyran-6-yl)methyl)thiazolidine-2',4-dione as an anti-atherosclerosis agent
DE3766885D1 (en) Chlorpheniramine therapie.
IE820151L (en) Treating shock using meptazinol
IL89902A0 (en) Preparation of 5-chloro-3-chlorosulphonyl-2 thiophene-carboxylic acid esters
EP0464135A4 (en) Method for reducing side effects of a drug
AU5220686A (en) Method of increasing heme excretion from a mammal using tin protoporphyrin
OA07728A (fr) Dérivés de l'acide bicyclo (3.2.1.) octane carboxylique, leur procédé de préparation et leur application thérapeutique.
GB2171920B (en) Mechanical horse for children's play
CS714987A1 (en) Connection for spinning machine's spinning units running securing espevially with break spinning machine
EP0351017A3 (en) Pharmaceutical composition useful for the treatment of cardiovascular diseases
ZA872204B (en) Etodolac for use in lowering uric acid blood levels
Mah Nutritional factors affecting clavulanic acid production by Streptomyces clavuligerus
Brennan Etiology of osteochondrosis of swine
EP0207405A3 (en) Pharmaceutical combination composition and associated method
KR960008652B1 (en) Method of increasing concentration of endogenous growth hormone of an economic mamals